Jefferies Starts Urovant Ltd. (UROV) at Buy
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/27/2026
- Wall Street ends higher on revived AI momentum
- Meta's $97.5B AI money grab: why Zuckerberg is racing to raise cash before rivals
- Deutsche Bank’s Reid sees potential final dip this year before Santa rally
- UPS tops estimates as efficiency drive gains momentum
- GM to move stock listing to Nasdaq in November, shares gain
- Microsoft to offer buyouts to 60,000 workers in cost-cutting move - Bloomberg
- S&P Global explores potential separation of Capital IQ business
- JetBlue shares drop on creditor restructuring news amid bankruptcy filing fears
- Celestica (CLS) Tops Q3 EPS by 31c, Offers Guidance
- Equities end higher as Anthropic's IPO filing buoys AI stocks
Cowen Starts Urovant Ltd. (UROV) at Outperform
October 22, 2018 5:39 AM EDTCowen analyst Rita Baral initiates coverage on Urovant Ltd. (NASDAQ: UROV) with a Outperform rating and a price target of $25.00.
The analyst comments "We expect vibegron to be successful in Ph3 trial, based on positive Ph2 precedent, and to be approved for OAB.... More
JPMorgan Starts Urovant Ltd. (UROV) at Overweight
October 22, 2018 4:06 AM EDTJPMorgan initiates coverage on Urovant Ltd. (NASDAQ: UROV) with a Overweight rating and a price target of $21.00.
For an analyst ratings summary and ratings history on Urovant Ltd. click here. For more ratings news on Urovant Ltd. click here.
Shares of Urovant Ltd. closed at $12.68 yesterday.
... More


